NIDA's naltrexone research program.
D002986:Clinical Trials as Topic; D003213:Conditioning, Psychological / Q000187:drug effects; D003496:Cyclazocine / Q000627:therapeutic use; D004341:Drug Evaluation; D005059:Euphoria / Q000187:drug effects; D003932:Heroin / Q000494:pharmacology; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D009270:Naloxone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000494:pharmacology; D012106:Research; D012109:Research Support as Topic; D014481:United States; D014482:United States Substance Abuse and Mental Health Services Administration
D009292:Narcotic Antagonists; D009270:Naloxone; D009271:Naltrexone; D003932:Heroin; D003496:Cyclazocine